DiNonA Inc (086080)

KONEX
Currency in KRW
3,785
0(0.00%)
Closed·
Showing DiNonA historical data. For real-time data please try another search
Day's Range
3,7003,880
52 wk Range
3,7003,880
Key Statistics
Edit
Bid/Ask
3,715.00 / 3,785.00
Prev. Close
3,800
Open
3,880
Day's Range
3,700-3,880
52 wk Range
3,700-3,880
Volume
-
Average Volume (3m)
6.52K
1-Year Change
0%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

DiNonA Company Profile

DiNonA Inc., a biopharmaceutical development company, researches, develops, and commercializes antibody related therapeutics and diagnostic reagents. Its pipeline products include DNP0007 that is in pre-clinical phase to treat immune suppression and rhenoid; DNP002, a product candidate that is in Phase I clinical trials to treat colon and stomach cancer; DNP005 and PD-1 to treat cancer; DNP019/COVID19 to treat SARS-CoV-2 infection; DNP004 that is in pre-clinical phase for the treatment of breast cancer; and DNP001 for the treatment of actue leukemia and cancer. The company offers monoclonal antibodies to treat hepatitis B virus, hepatocarcinoma, diabetes, superbacteria MRSA, myocardial infraction, and cancer. The company was founded in 1999 and is headquartered in Seoul, South Korea. DiNonA Inc. was acquired by Kumho HT, Inc.

Earnings

Latest Release
Mar 11, 2020
EPS / Forecast
-408.09 / --
Revenue / Forecast
708.90M / --
EPS Revisions
Last 90 days

086080 Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.